Alcohol Metabolizing Enzymes, Microsomal Ethanol Oxidizing System, Cytochrome P450 2E1, Catalase, and Aldehyde Dehydrogenase in Alcohol-Associated Liver Disease

被引:179
作者
Jiang, Yanchao [1 ]
Zhang, Ting [1 ]
Kusumanchi, Praveen [1 ]
Han, Sen [1 ]
Yang, Zhihong [1 ]
Liangpunsakul, Suthat [1 ,2 ]
机构
[1] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA
[2] Roudebush Vet Adm, Med Ctr, Indianapolis, IN 46202 USA
关键词
alcohol metabolizing enzyme; cytochrome P450 2E1; and alcohol-associated liver disease; CCAAT/ENHANCER-BINDING-PROTEIN; UPSTREAM STIMULATORY FACTOR; RECEPTOR RESPONSE ELEMENT; FATTY LIVER; GENETIC-POLYMORPHISM; LIPID-PEROXIDATION; IN-VIVO; TRANSCRIPTIONAL CONTROL; CIRRHOSIS MORTALITY; RSAI POLYMORPHISM;
D O I
10.3390/biomedicines8030050
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Once ingested, most of the alcohol is metabolized in the liver by alcohol dehydrogenase to acetaldehyde. Two additional pathways of acetaldehyde generation are by microsomal ethanol oxidizing system (cytochrome P450 2E1) and catalase. Acetaldehyde can form adducts which can interfere with cellular function, leading to alcohol-induced liver injury. The variants of alcohol metabolizing genes encode enzymes with varied kinetic properties and result in the different rate of alcohol elimination and acetaldehyde generation. Allelic variants of these genes with higher enzymatic activity are believed to be able to modify susceptibility to alcohol-induced liver injury; however, the human studies on the association of these variants and alcohol-associated liver disease are inconclusive. In addition to acetaldehyde, the shift in the redox state during alcohol elimination may also link to other pathways resulting in activation of downstream signaling leading to liver injury.
引用
收藏
页数:16
相关论文
共 141 条
[1]
Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease [J].
Anstee, Quentin M. ;
Seth, Devanshi ;
Day, Christopher P. .
GASTROENTEROLOGY, 2016, 150 (08) :1728-+
[2]
Chronic Ethanol Metabolism Inhibits Hepatic Mitochondrial Superoxide Dismutase via Lysine Acetylation [J].
Assiri, Mohammed A. ;
Roy, Samantha R. ;
Harris, Peter S. ;
Ali, Hadi ;
Liang, Yongliang ;
Shearn, Colin T. ;
Orlicky, David J. ;
Roede, James R. ;
Hirschey, Matthew D. ;
Backos, Donald S. ;
Fritz, Kristofer S. .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2017, 41 (10) :1705-1714
[3]
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal [J].
Ayala, Antonio ;
Munoz, Mario F. ;
Argueelles, Sandro .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2014, 2014
[4]
BECK IT, 1974, GASTROENTEROLOGY, V67, P484
[5]
Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study [J].
Becker, U ;
Deis, A ;
Sorensen, TIA ;
Gronbaek, M ;
BorchJohnsen, K ;
Muller, CF ;
Schnohr, P ;
Jensen, G .
HEPATOLOGY, 1996, 23 (05) :1025-1029
[6]
Lower risk for alcohol-induced cirrhosis in wine drinkers [J].
Becker, U ;
Gronbæk, M ;
Johansen, D ;
Sorensen, TIA .
HEPATOLOGY, 2002, 35 (04) :868-875
[7]
Genetic polymorphism of alcohol dehydrogenase in Europeans:: The ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1 [J].
Borràs, E ;
Coutelle, C ;
Rosell, A ;
Fernández-Muixi, F ;
Broch, M ;
Crosas, B ;
Hjelmqvist, L ;
Lorenzo, A ;
Gutiérrez, C ;
Santos, M ;
Szczepanek, M ;
Heilig, M ;
Quattrocchi, P ;
Farrés, J ;
Vidal, F ;
Richart, C ;
Mach, T ;
Bogdal, J ;
Jörnvall, H ;
Seitz, HK ;
Couzigou, P ;
Parés, X .
HEPATOLOGY, 2000, 31 (04) :984-989
[8]
RELATIONSHIP BETWEEN KINETICS OF LIVER ALCOHOL-DEHYDROGENASE AND ALCOHOL METABOLISM [J].
BOSRON, WF ;
CRABB, DW ;
LI, TK .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 18 :223-227
[9]
Cytosolic xanthine oxidoreductase mediated bioactivation of ethanol to acetaldehyde and free radicals in rat breast tissue.: Its potential role in alcohol-promoted mammary cancer [J].
Castro, GD ;
de Layño, AMAD ;
Costantini, MH ;
Castro, JA .
TOXICOLOGY, 2001, 160 (1-3) :11-18
[10]
Cederbaum Arthur I., 2012, Drug Metabolism and Drug Interactions, V27, P125, DOI 10.1515/dmdi-2012-0014